Countries in APAC serve vital growth opportunities due to the continuously growing population, including geriatric populations. The heavy investments encourage the adoption of advanced technologies in the healthcare sector. According to the Organization for Economic Co-operation and Development (OECD), China was a frontrunner in terms of R&D expenditure in 2019. Furthermore, growing support from governments, continuously changing disease profiles, rising public-private partnerships, and increasing funding activities are widely enhancing the performance of biotechnology research centers in APAC region, which creates enormous opportunities for the frozen tissue samples market players in this region.
Governments in APAC offer tax incentives, cheaper land, incubators, and direct investments to encourage the growth of local biotechnology companies by allowing them to expand their abilities and capacities, which paves way for the progress of the frozen tissue sample market. Countries such as Malaysia, Taiwan, Singapore, India, China, and Japan are among the most favorable destinations for the biotechnology research industry. Moreover, in Asian countries, frozen tissue samples are used to analyze proteomics, next-generation sequencing, and diagnostic and therapeutic biomarker exploration applications.
With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the APAC frozen tissues samples market at a notable CAGR during the forecast period.
The APAC frozen tissues samples market is segmented on the basis of product type, application, end user, and country. The market, based on product, is segmented into frozen normal tissues samples, frozen tumor tissues samples, and frozen diseased tissue samples. The frozen tissue tumor samples segment held the largest share of the market in 2021. Based on application, the APAC frozen tissues samples market is segmented into disease diagnosis and treatment, cancer and other diseases research, and morphological analysis. In 2021, the cancer and other diseases research segment accounted for the largest share of the market. The APAC frozen tissues samples market, by end user, is segmented into academic and research institutes, hospitals and clinics, diagnostic centers, and others. In 2021, the academic and research institutes segment held the largest market share. Based on country, the APAC frozen tissues samples market is segmented into Australia, China, India, Japan, South Korea, and Rest of APAC.
AMS Biotechnology Ltd.; Audubon Bioscience Co; Bay Biosciences LLC; BioChain Institute Inc.; OriGene Technologies, Inc.; ProteoGenex, Inc.; REPROCELL Inc.; and ZenBio, Inc. are among the leading companies in the APAC frozen tissues samples market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 91.32 Million |
| Market Size by 2028 | US$ 23.73 Million |
| CAGR (2021 - 2028) | 14.6% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Product Type
|
| Regions and Countries Covered |
Asia-Pacific
|
| Market leaders and key company profiles |
|
The Asia Pacific Frozen Tissues Samples Market is valued at US$ 91.32 Million in 2021, it is projected to reach US$ 23.73 Million by 2028.
As per our report Asia Pacific Frozen Tissues Samples Market, the market size is valued at US$ 91.32 Million in 2021, projecting it to reach US$ 23.73 Million by 2028. This translates to a CAGR of approximately 14.6% during the forecast period.
The Asia Pacific Frozen Tissues Samples Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Frozen Tissues Samples Market report:
The Asia Pacific Frozen Tissues Samples Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Frozen Tissues Samples Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Frozen Tissues Samples Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)